Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer.
Petrioli R, Marrelli D, Roviello F, D'Ignazio A, Torre P, Chirra M, Savelli V, Ambrosio MR, Francini G, Calomino N, Farsi M, Vernillo R, Francini E. Petrioli R, et al. Among authors: francini g, francini e. Surg Oncol. 2020 Mar;32:2-7. doi: 10.1016/j.suronc.2019.10.002. Epub 2019 Oct 2. Surg Oncol. 2020. PMID: 31670056
Weekly chemotherapy in advanced prostatic cancer.
Francini G, Petrioli R, Manganelli A, Cintorino M, Marsili S, Aquino A, Mondillo S. Francini G, et al. Br J Cancer. 1993 Jun;67(6):1430-6. doi: 10.1038/bjc.1993.265. Br J Cancer. 1993. PMID: 8512828 Free PMC article. Clinical Trial.
Weekly epirubicin in patients with hormone-resistant prostate cancer.
Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, Francini G. Petrioli R, et al. Among authors: francini g. Br J Cancer. 2002 Sep 23;87(7):720-5. doi: 10.1038/sj.bjc.6600525. Br J Cancer. 2002. PMID: 12232753 Free PMC article. Clinical Trial.
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Petrioli R, Pascucci A, Conca R, Chiriacò G, Francini E, Bargagli G, Fiaschi AI, Manganelli A, De Rubertis G, Barbanti G, Ponchietti R, Francini G. Petrioli R, et al. Among authors: francini g, francini e. Br J Cancer. 2011 Feb 15;104(4):613-9. doi: 10.1038/bjc.2011.5. Epub 2011 Feb 1. Br J Cancer. 2011. PMID: 21285986 Free PMC article. Clinical Trial.
142 results